Thrombosis in Haematological Disorders: Tailored Management Approaches - European Medical Journal

Thrombosis in Haematological Disorders: Tailored Management Approaches

Download PDF
Anna Falanga1
T. Sakari Jokiranta,2 Anita Hill3

Anna Falanga has received speaker fees, consultancy, and research support from Alexion Pharmaceuticals. T. Sakari Jokiranta has received honoraria for lectures from Pfizer, Merck Sharp & Dohme, Alexion Pharmaceuticals, Scopeful, Abbvie, Medac, and Roche, received consultation fees from Pfizer, Merck Sharp & Dohme, and Alexion Pharmaceuticals, and is a shareholder for Scopeful. Anita Hill has received honoraria from Alexion Pharmaceuticals and served on advisory boards.


Writing assistance was provided by Dr Saroshi Amirthalingam, apothecom scopemedical Ltd.


The publication of this article was funded by Alexion. The views and opinions expressed are those of the authors and not necessarily of Alexion.

EMJ Hema. ;3[1]:38-46. DOI/10.33590/emjhematol/10312317.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Meeting Summary

The meeting commenced with a talk from Prof Anna Falanga on the management of thrombosis in both onco-haematological and non-oncological diseases. Adjunct Prof Sakari Jokiranta gave an overview of the complement system and the interplay between the complement and coagulation systems. Dysregulation of complement and resulting disease states were also discussed. The session was concluded with a presentation from Dr Anita Hill on the management of thrombosis in paroxysmal nocturnal haemoglobinuria (PNH).

Please view the full content in the pdf above.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally